swot.png
 

STRENGTHS

  •  Strong presence in Europe, especially in Italy
  •  Supported by a big pharmaceutical group
 

OPPORTUNITIES

  • Helios / Helmed+Aeskuslides
  • One Aesku concept for the ELISAs
  • G+M+A kits
  • As a developer, responsiveness regardless of markers
 

WEAKNESSES

  • No product development
  • The reagents they currently distribute are of lower quality than when they were distributing INOVA reagents
 

THREATS

  • Capability to finance OEM systems
  • Uniqo a new solution?